|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/16/2024 |
$0.78 |
$0.80 |
$0.75 |
$0.77 |
553.00K | 04/17/2024 |
$0.75 |
$0.78 |
$0.70 |
$0.71 |
426.40K | 04/18/2024 |
$0.72 |
$0.77 |
$0.71 |
$0.77 |
230.70K | 04/19/2024 |
$0.72 |
$0.77 |
$0.71 |
$0.73 |
238.10K | 04/22/2024 |
$0.71 |
$0.72 |
$0.67 |
$0.71 |
164.60K |
|
Aptevo Therapeutics is a clinical-stage, research and development biotechnology company focused on developing immunotherapeutic candidates for the treatment of different forms of cancer. Co.'s lead clinical candidates, APVO436 and ALG.APV-527, and preclinical candidates, APVO603 and APVO711, were developed using Co.'s ADAPTIR modular protein technology platform. Co.'s preclinical candidate APVO442 was developed using its ADAPTIR-FLEX modular protein technology platform. Co.'s ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of improving the human immune system against cancer cells. | |
|
Aptevo Therapeutics (APVO) has the following price history information. Looking back at APVO historical stock prices for the last five trading days, on April 16, 2024, APVO opened at $0.78, traded as high as $0.80 and as low as $0.75, and closed at $0.77. Trading volume was a total of 553.00K shares. On April 17, 2024, APVO opened at $0.75, traded as high as $0.78 and as low as $0.70, and closed at $0.71. Trading volume was a total of 426.40K shares. On April 18, 2024, APVO opened at $0.72, traded as high as $0.77 and as low as $0.71, and closed at $0.77. Trading volume was a total of 230.70K shares. On April 19, 2024, APVO opened at $0.72, traded as high as $0.77 and as low as $0.71, and closed at $0.73. Trading volume was a total of 238.10K shares. On April 22, 2024, APVO opened at $0.71, traded as high as $0.72 and as low as $0.67, and closed at $0.71. Trading volume was a total of 164.60K shares.
APVO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aptevo Therapeutics shares, starting with a $10,000 purchase of APVO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
07/21/2016 |
|
End date: |
04/22/2024 |
|
Start price/share: |
$4,928.00 |
|
End price/share: |
$0.71 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.99% |
|
Average Annual Total Return: |
-68.02% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1.44 |
|
Years: |
7.76 |
|
|
|
Date |
Close |
04/16/2024 | $0.77 | 04/17/2024 | $0.71 | 04/18/2024 | $0.77 | 04/19/2024 | $0.73 | 04/22/2024 | $0.71 |
|
|